Lifeboat Foundation

In April, Tesla Inc TSLA CEO Elon Musk said he was done selling Tesla shares to help finance his ongoing overhaul at Twitter.

Since then, he jettisoned more than $20 billion worth of Tesla stock and has continued the selling spree this week.

As the stock continues to skid, Jim Cramer sees an electric buying opportunity.

Synchron, a neurovascular bioelectronics medicine company, today announced publication of a first-in-human study demonstrating successful use of the Stentrode™ brain-computer interface (BCI), or neuroprosthesis. Specifically, the study shows the Stentrode’s ability to enable patients with severe paralysis to resume daily tasks, including texting, emailing, shopping and banking online, through direct thought, and without the need for open brain surgery. The study is the first to demonstrate that a BCI implanted via the patient’s blood vessels is able to restore the transmission of brain impulses out of the body, and did so wirelessly. The patients were able to use their impulses to control digital devices without the need for a touchscreen, mouse, keyboard or voice activation technology. This feasibility study was published in the Journal of NeuroInterventional Surgery (JNIS), the leading international peer-review journal for the clinical field of neurointerventional surgery, and official journal of the Society of NeuroInterventional Surgery (SNIS).

Making the total amount of sold Tesla stocks nearly $40 billion over the past year.

Tesla CEO, Elon Musk, has been on a selling spree of his company’s stock this year. Earlier this week, Musk sold 22 million shares over a period of three days, a filing with the U.S. financial regulator has revealed, the BBC

Musk, who rose to the top of the world’s wealthiest people list last year riding on Tesla stock price, has spent most of 2022 dealing with this start-again-stop-again campaign to acquire Twitter. Musk, who was quite secretive about acquiring Twitter stock at the beginning of the year, shocked many by declaring his intent to buy out the social media company and take it private.

In a move to protect SBFs hedge fund from losing billions software code was altered.

Sam Bankman-Fried owned Alameda Research, a hedge fund heavily invested in FTX. In move to make sure the hedge fund assets were never sold off, when FTX began to have issues, an engineer secretly changed software code in the FTX system. The software would have sold off all Alameda Research assets, just like any other companies that were owned, in the case of FTX filing for bankruptcy.

Getty Images.

Continue reading “FTX caught depositing 8 billion dollars of customer money into secret accounts” »

“Advent has a proven record of strengthening its portfolio companies and a desire to support Maxar in advancing our long-term strategic objectives,” Maxar CEO Daniel Jablonsky said in the statement. “As a private company, we will have enhanced flexibility and additional resources to build on Maxar’s strong foundation, further scale operations and capture the significant opportunities in a rapidly expanding market.”

With some $28 billion invested across the defense, security and cybersecurity sectors in the last three years, Boston-based Advent’s portfolio companies support many satellite and defense platforms which serve the U.S. government and its allies as well as companies across the globe. The firm said it arranged debt and equity financing commitments to finance the acquisition.

The transaction is expected to close mid-2023, subject to customary closing conditions. Maxar, which has 4,400 employees, will operate under the same brand and maintain its headquarters in Westminster, Colorado, and will remain U.S.-controlled and operated.

The forecast, first reported by Reuters, represents how some in Silicon Valley are betting the underlying technology will go far beyond splashy and sometimes flawed public demos.

OpenAI was most recently valued at $20 billion in a secondary share sale, one of the sources said. The startup has already inspired rivals and companies building applications atop its generative AI software, which includes the image maker DALL-E 2. OpenAI charges developers licensing its technology about a penny or a little more to generate 20,000 words of text, and about 2 cents to create an image from a written prompt, according to its website.

A spokesperson for OpenAI declined to comment on its financials and strategy. The company, which started releasing commercial products in 2020, has said its mission remains advancing AI safely for humanity.

Standing among solar arrays and power grid equipment at the National Renewable Energy Laboratory (NREL), you might hear a faint, distorted melody buzzing from somewhere. You are not hallucinating—that gray box really is singing the Star Wars Theme, or the ice cream truck song, or Chopin’s Waltz in A minor. Power system engineers are just having some fun with an NREL capability that prevents stability problems on the electrical grid.

Usually, the engineers send another kind of waveform through the inverters and load banks: megawatts of power and voltage vibrations at many frequencies. The purpose of their research is to see how energy devices and the grid interact—to get them “in tune” and prevent dangerous electrical oscillations that show up like screechy feedback or a booming sub-bass.

Continue reading “Singing inverters show electrical harmony for renewable power systems” »

Structuring, Financing & Growing Novel Longevity Ventures — Dr. Tobias Reichmuth Ph.D., Founding Partner, Maximon

Dr. Tobias Reichmuth, Ph.D. is Founding Partner at Maximon (https://www.maximon.com/), The Longevity Company Builder, which empowers entrepreneurs to build impactful, science-based and scalable companies providing healthy aging and rejuvenation solutions.

Continue reading “Dr. Tobias Reichmuth, Ph.D. — Maximon — Structuring, Financing & Growing Novel Longevity Ventures” »

Japan wants to get back into the leading-edge semiconductor business and very recently a new company was formed to reboot its semiconductor industry. The company is named Rapidus, referring to rapid production of new chips, a clear reference to how the company plans to differentiate its business from other foundries such as TSMC, Samsung, and Intel. The company has announced a partnership with IBM Research to develop IBM’s 2nm technology in fabs that Rapidus plans to build in Japan during the second part of this decade. Previously, Rapidus announced a collaboration with the Belgium-based microelectronics research hub IMEC on advanced semiconductor technologies. Imec is collaborative semiconductor research organization working the world’s major foundries, IDMs, fabless and fablite companies, material and tool suppliers, EDA companies and application developers.

The IBM process uses gate-all-around transistors — IBM refers to them as nano sheet FETs — which is the next generation of transistor design that enables device scaling beyond today’s FinFETs. The 2nm structures will require Rapidus to use ASML’s EUV manufacturing equipment. Business details with IBM were not disclosed, but there’s likely two parts to the deal: a cross-licensing agreement for the intellectual property necessary to build the product and a joint development agreement. While the announcement is nominally for IBM’s 2nm process, it likely includes a long-term commitment to build advanced semiconductor chips going beyond the 2nm process node.

Rapidus was formed by semiconductor veterans such as Rapidus President Atsuyoshi Koike, with backing by leading Japanese technology and financial firms, including Denso, Kioxia, Mitsubishi UFJ Bank, NEC, NTT, Softbank, Sony, and Toyota Motor. The Japanese government is also subsidizing Rapidus. The big change for Japan compared to prior national efforts is the collaboration with international organizations. It’s a recognition Japan cannot go it alone. This appears to be a fundamental change in Japanese attitudes. Building a fab in Japan will be helped by Japan’s strong manufacturing ecosystem of materials, equipment, and engineering talent.